Home > Income Statement > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Revenue

    Back to Income Statement
BAFNA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Revenue History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹152 Cr₹115 Cr₹85 Cr₹71 Cr₹42 Cr

What is the latest Revenue of BAFNA PHARMACEUTICALS ?

The latest Revenue ratio of BAFNA PHARMACEUTICALS is ₹152 Cr based on Mar2025 Standalone results.
Year Revenue
Mar2025₹152 Cr
Mar2024₹115 Cr
Mar2023₹85 Cr
Mar2022₹71 Cr
Mar2021₹42 Cr

How is Revenue of BAFNA PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹152 Cr
32.18
Mar2024 ₹115 Cr
35.48
Mar2023 ₹85 Cr
19.55
Mar2022 ₹71 Cr
67.68
Mar2021 ₹42 Cr -

Compare Revenue of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹634.7 Cr 7.6% 19% 221.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹477,312.0 Cr 0.8% 6.3% 18.2% Stock Analytics
DIVIS LABORATORIES ₹213,879.0 Cr 8.6% 20.7% 18.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹194,094.0 Cr 1.7% 9.4% 38.5% Stock Analytics
CIPLA ₹118,992.0 Cr 4.5% 1.2% -1.4% Stock Analytics
DR REDDYS LABORATORIES ₹95,787.4 Cr -0.3% -14.8% -9.5% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

7.6%

19%

221.8%

SENSEX

2.7%

1.5%

-5.6%


You may also like the below Video Courses